These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38760835)

  • 1. Metabolic landscape and pathogenic insights: a comprehensive analysis of high ovarian response in infertile women undergoing in vitro fertilization.
    Ruan LL; Lv XY; Hu YL; Chen MX; Jing-Tang ; Zhong ZH; Bao MH; Fu LJ; Luo X; Yu SM; Wan Q; Ding YB
    J Ovarian Res; 2024 May; 17(1):105. PubMed ID: 38760835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrafollicular fluid metabolic abnormalities in relation to ovarian hyperstimulation syndrome: Follicular fluid metabolomics via gas chromatography-mass spectrometry.
    Sun Y; Hao L; Han W; Luo J; Zheng J; Yuan D; Ye H; Li Q; Huang G; Han T; Yang Z
    Clin Chim Acta; 2023 Jan; 538():189-202. PubMed ID: 36566958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Letrozole (LE) in controlled ovarian stimulation (COS) in patients at high risk to develop ovarian hyper stimulation syndrome (OHSS). A prospective randomized controlled pilot study.
    Tshzmachyan R; Hambartsoumian E
    J Gynecol Obstet Hum Reprod; 2020 Feb; 49(2):101643. PubMed ID: 31563697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI.
    Sun B; Ma Y; Li L; Hu L; Wang F; Zhang Y; Dai S; Sun Y
    Front Endocrinol (Lausanne); 2020; 11():615957. PubMed ID: 33542709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes.
    Cela V; Obino MER; Alberga Y; Pinelli S; Sergiampietri C; Casarosa E; Simi G; Papini F; Artini PG
    Gynecol Endocrinol; 2018 Jun; 34(6):518-523. PubMed ID: 29271274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.
    Tal R; Seifer DB; Shohat-Tal A; Grazi RV; Malter HE
    Fertil Steril; 2013 Aug; 100(2):538-43. PubMed ID: 23684116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of assistant treatment proposals for infertile women with polycystic ovary syndrome].
    Chen ZJ; Shi YH; Li Y; Gao Q; Sheng Y; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):571-5. PubMed ID: 19087489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN; Peng JL; Yang J; Xu WM
    Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial.
    Zheng X; Guo W; Zeng L; Zheng D; Yang S; Xu Y; Wang L; Wang R; Mol BW; Li R; Qiao J
    Hum Reprod; 2022 Jan; 37(2):242-253. PubMed ID: 34849920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility.
    Okohue JE; Onuh SO; Ikimalo JI
    Niger J Clin Pract; 2013; 16(2):207-10. PubMed ID: 23563463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular-Phase GnRH Agonist Protocol Is Another Choice for Polycystic Ovary Syndrome Patients With Lower LH/FSH and Lower AMH Levels Without Increasing Severe OHSS Risk.
    Gao R; Liao X; Huang W; Zeng R; Qin L; Bai P
    Front Endocrinol (Lausanne); 2022; 13():905263. PubMed ID: 35757417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Essential Role of Body Weight in Adjusting Gn Dosage to Prevent High Ovarian Response for Women With PCOS During IVF: A Retrospective Study.
    Zeng R; Chen H; Zeng X; Qin L
    Front Endocrinol (Lausanne); 2022; 13():922044. PubMed ID: 35846308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low-dose aspirin on the development of ovarian hyperstimulation syndrome and outcomes of assisted reproductive techniques in the women with PCOS, a randomized double-blinded clinical trial.
    Namavar Jahromi B; Zolghadri J; Rahmani E; Alipour S; Anvar Z; Zarei A; Keramati P
    Taiwan J Obstet Gynecol; 2019 Mar; 58(2):255-260. PubMed ID: 30910149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing
    Yang L; Liang F; Yuan Y; Luo X; Wang Q; Yao L; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1224858. PubMed ID: 37795363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcome of in vitro fertilization-embryo transfer in treatment of polycystic ovarian syndrome].
    Lu XE; Yang XF; Li MG; Zhou FZ; Zhu YM; Huang HF
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 May; 35(3):319-22. PubMed ID: 16764037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro fertilization outcomes in women with polycystic ovary syndrome: A meta-analysis.
    Tang K; Wu L; Luo Y; Gong B
    Eur J Obstet Gynecol Reprod Biol; 2021 Apr; 259():146-152. PubMed ID: 33676123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoinositol
    Rajasekaran K; Malhotra N; Mahey R; Khadgawat R; Kalaivani M
    Gynecol Endocrinol; 2022 Feb; 38(2):140-147. PubMed ID: 34590929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive evaluation of progestin-primed ovarian stimulation protocol in patients with or without PCOS undergoing in vitro fertilization.
    Zhu J; Zhang J; Yang J; Li D; Wang C; Elizur SE; Zhao K; Kuang Y; Wang Y
    Reprod Biol; 2021 Dec; 21(4):100540. PubMed ID: 34416405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
    Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.